Home
Name
CHD-R
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for CHD-R
Name
Alternate Names
ENT 50852
ENT-50852
Hemel
Hexalen
hexamethyl- (8CI)
Hexamethylenamine
Hexamethylmelamine
Hexastat
Melamine
NC 195
NCI-C50259
Abbreviations
HMM
HTM
HXM
Category
Chemotherapy
Subcategory
Ccytotoxic antineoplastic
NSC Number
013875
13875
Primary Site
Ovarian cancer
Histology
None
Remarks
Coding
This drug should be coded
Name
Alternate Names
Cis-Platin
Cis-Platinum II#
Cisplatino (Spanish)
Cisplatinum
Cisplatyl
Neoplatin
Peyrone's chloride
Platinex
Platinol
Platinol-AQ
Platinol-AQ VHA Plus
Platinum
Abbreviations
CACP
CDDP
Cis-DDP
CPD
CPDC
CPDD
CPPD
DDP
Category
Chemotherapy
Subcategory
Alkylating agent
Platinum analog
NSC Number
119875
Primary Site
Histology
None
Remarks
An alkylating antineoplastic agent. FDA approved uses on bladder, ovarian and testicular cancer; miscellaneous agent.
Coding
This drug should be coded
Name
Alternate Names
Ancef
Apo-Cefaclor
Apo-Cephalex
Ceclor
Ceclor CD
Cedax
Cefaclor
Cefadroxil
Cefadyl
Cefamandole
Cefazolin
Cefdinir
Cefditoren
Cefepime
Cefixime
Cefizox
Cefobid
Cefonicid
Cefoperazone
Cefotan
Cefotaxime
Cefotetan
Cefoxitin
Cefpodoxime
Cefprozil
Ceftazidime
Ceftibuten
Ceftin
Ceftizoxime
Ceftriaxone
Cefuroxime
Cefzil
Cephalexin
Cephalothin
Cephapirin
Cephradine
Ceporacin
Ceptaz
Claforan
Duricef
Fortaz
Keflex
Keflin
Keftab
Kefurox
Kefzol
Mandol
Maxipime
Mefoxin
Monocid
Novo-Lexin
Nu-Cephalex
Omnicef
PMS-Cephalexin
Rocephin
Suprax
Tazicef
Tazidime
Vantin
Velosef
Zinacef
Abbreviations
None
Category
Ancillary Agent
Subcategory
Antibacterial
NSC Number
None
Primary Site
None
Histology
None
Remarks
None
Coding
This drug should NOT be coded
Name
Alternate Names
Asta B 518
B-518
Clafen Claphene
Cyclophosphamid
Cyclophosphan
Cyclophosphane
Cytophosphan
Cytoxan
Endoxan
Endoxana
Enduxan
Genoxal
Neosar
Procytox
Sendoxan
Tymtram
WR-138719
Abbreviations
CP
CPM
CTX
CTY
CYC
Cyclo
CYT
CYTOX
CYTX
Category
Chemotherapy
Subcategory
Alkylating agent
NSC Number
026271
26271
Primary Site
Breast
leukemia
lymphoma
multiple myeloma
neuroblastoma
ovarian cancer
retinoblastoma
soft tissue sarcoma
Wilm's tumor
Histology
None
Remarks
An effective antineoplastic agent and is used for a variety of cancers. FDA approved uses on breast cancer, ovarian carcinoma, leukemia, lymphomas, multiple myeloma, neuroblastma, retinoblastoma, soft tissue sarcoma, Wilm's tumor. Alkylating agent
Coding
This drug should be coded
